GLP1R and diabetes mellitus: Nadeem et al. conducted a retrospective study with 35,183 patients who underwent EGD and found that the use of GLP-1 RAs was associated with a fourfold increase in gastric content retention, a fourfold rise in aborted EGDs, and a doubling in the need for repeat procedures, even when adjusting for diabetes [9].